http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113491272-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-07
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08
filingDate 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113491272-B
titleOfInvention Application of flavonoid glycoside compound in resisting tobacco mosaic virus and preparation method thereof
abstract The invention discloses application of flavonoid glycoside compounds in resisting tobacco mosaic virus and a preparation method thereof, wherein the three compounds are kaempferol-3-O-alpha-rhamnoside, isovitexin 6' -O-E-p-coumaric acid and quercetin-3-O-beta-glucuronic acid respectively, and the three compounds can be used for resisting the tobacco mosaic virus. Experiments show that the passivation effect of the three compounds on TMV is better than that of the commercial medicament ningnanmycin, and the systemic resistance effect of the compound II on TMV on common tobacco is better than that of ningnanmycin, so that the three compounds have good passivation, protection and treatment effects on TMV and can be used as plant antiviral agents and plant immunity inducing agents.
priorityDate 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5316673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12047524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44588235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426321743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 45.